We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




World's First AI-Ready Infrasound Stethoscope Listens to Bodily Sounds Not Audible to Human Ear

By HospiMedica International staff writers
Posted on 12 Apr 2022

Bodily sounds that cannot be heard by humans contain clinically significant data that can help diagnose clinical conditions. More...

Until now, this vital information was not available. A new technology draws lifesaving medical insights from listening to these inaudible bodily sounds and combines AI to provide disease classification for cardiopulmonary diseases, including COPD, pneumonia, asthma, and cardiac morbidities.

Sanolla (Nesher, Israel) has launched the AI-ready VoqX, the first stethoscope in the world that can listen to infrasound - acoustic waves that cannot be heard by humans. Sanolla’s smart infrasound stethoscope could replace all of today's archaic-technology stethoscopes. Sanolla's novel technology, dubbed "The Sounds of Life", picks up clinically rich low-frequency sound waves (3-40Hz), also known as infrasound, which are not audible to the human ear yet carry diagnostic information beyond what is available in the audible spectrum only. The VoqX's smart signal processing shifts sounds to the ear's most sensitive frequency range and coupled with dynamic noise cancelation provides an exceptional auscultation experience.

VoqX detects infrasound and audible sounds, identifies clinical condition based on the company’s AI algorithms and displays diagnosis through its proprietary sound signature image. This can reduce the need for CT or X-ray radiation or invasive blood tests and provide health care professionals with precise, fast diagnosis. Sanolla has developed AI algorithms for disease classification that provide unmatched disease classification for many cardiopulmonary diseases including COPD, pneumonia, asthma, and cardiac morbidities. The AI algorithms make full use of the infrasound information that will be uploaded to the AI-ready VoqX upon their regulatory clearance. The company has submitted 20 patent applications, eight of which have already been granted. Sanolla has been granted FDA 510(k) clearance for the clinical use of the AI-ready VoqX, following the regulatory approval granted recently by the Israeli Health Ministry. The regulatory approvals enable Sanolla to immediately make the VoqX available for clinical use in the US and Israel.

"FDA clearance is an important milestone for Sanolla. The VoqX, which has been used extensively for studies in the United States, Europe and Israel, is now available for clinical use," said Dr. Doron Adler, Sanolla's co-founder and CEO.

"The VoqX is an excellent tool for diagnosing cardiopulmonary morbidities including valvular pathologies," said Dr. Michael Wasserman, MD, a recognized expert on geriatric care and a member of federal and state advisory committees. "Its acoustic optimization and dynamic noise cancellation make the VoqX an indispensable tool for physicians in any environment and is expected to improve early detection of heart and lung diseases at the primary care level by general practitioners."

Related Links:
Sanolla 


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ultrasonic Dissector
SONICBEAT
New
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.